1. Clement, SC, Peeters, RP, Ronckers, CM, et al. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma—a systematic review. Cancer Treat Rev. 2015;41(10):925–934.
Google Scholar | Crossref | Medline2. Klein Hesselink, EN, Brouwers, AH, de Jong, JR, et al. Effects of radioiodine treatment on salivary gland function in patients with differentiated thyroid carcinoma: a prospective study. J Nucl Med. 2016;57(11):1685–1691.
Google Scholar | Crossref | Medline3. Jeong, SY, Kim, HW, Lee, S-W, Ahn, BC, Lee, J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2013;23(5):609–616.
Google Scholar | Crossref | Medline4. Mandel, SJ, Mandel, L. Radioactive iodine and the salivary glands. Thyroid. 2003;13(3):265–271.
Google Scholar | Crossref | Medline5. Mandel, L, Liu, F. Salivary gland injury resulting from exposure to radioactive iodine. J Am Dent Assoc. 2007;138(12):1582–1587.
Google Scholar | Crossref | Medline6. Corrêa, LG, Moriguchi, SM, Boldrini, É.Evaluation of quality of life related to I-131 therapy in patients with well-differentiated thyroid cancer and emphasis in salivary morbidity : a follow up study after treatment. Adv Biosci Biotechnol. 2014;5(5):409–417.
Google Scholar | Crossref7. La Perle, KMD, Kim, DC, Hall, NC, et al. Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid. 2013;23(8):1029–1036.
Google Scholar | Crossref | Medline8. Wapnir, IL, Van De Rijn, M, Nowels, K, et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab. 2003;88(4):1880–1888.
Google Scholar | Crossref | Medline9. Caglar, M, Tuncel, M, Alpar, R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27(11):767–771.
Google Scholar | Crossref | Medline10. Grundmann, O, Mitchell, GC, Limesand, KH. Critical review in oral biology and medicine: sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res. 2009;88(10):894–903.
Google Scholar | SAGE Journals | ISI11. Schwarzenboeck, SM, Rauscher, I, Bluemel, C, et al. PSMA ligands for PET imaging of prostate cancer. J Nucl Med. 2017;58(10):1545–1552.
Google Scholar | Crossref | Medline12. Klein Nulent, TJW, Valstar, MH, de Keizer, B, et al. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(5):478–486. doi:10.1016/J.OOOO.2018.01.011
Google Scholar | Crossref | Medline13. Verma, P, Malhotra, G, Agrawal, R, Sonavane, S, Meshram, V, Asopa, RV. Evidence of prostate-specific membrane antigen expression in metastatic differentiated thyroid cancer using 68Ga-PSMA-HBED-CC PET/CT. Clin Nucl Med. 2018;43(8):e265–e268.
Google Scholar | Crossref | Medline14. van Luijk, P, Pringle, S, Deasy, JO, et al. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015;7(305):305ra147.
Google Scholar | Crossref | Medline15. Raza, H, Khan, AU, Hameed, A, Khan, A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27(6):495–499.
Google Scholar | Crossref | Medline16. Takagi, Y, Sumi, M, Nakamura, H, Sato, S, Kawakami, A, Nakamura, T. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with sjögren’s syndrome. Rheumatol (Oxford). 2015;55(2):237–245.
Google Scholar | Crossref | Medline17. Astreinidou, E, Roesink, JM, Raaijmakers, CPJ, et al. 3D MR sialography as a tool to investigate radiation-induced xerostomia: feasibility study. Int J Radiat Oncol Biol Phys. 2007;68(5):1310–1319.
Google Scholar | Crossref | Medline18. Dirix, P, Nuyts, S, Van Den Bogaert, W.Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. 2006;107(11):2525–2534.
Google Scholar | Crossref | Medline | ISI19. Jentzen, W, Balschuweit, D, Schmitz, J, et al. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging. Eur J Nucl Med Mol Imaging. 2010;37(12):2298–2306.
Google Scholar | Crossref | Medline20. Gonzalez, ME, Muttikkal, TJ, Rehm, PK. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone—thyrotropin alfa). J Radiol Case Rep. 2015;9(6):44–49.
Google Scholar | Medline21. Meltzer, DE, Gebara, NV, Goel, SR, Ghesani, M, Kuriloff, DB, Shatzkes, DR. Asymmetric I-131 uptake in the submandibular gland in the setting of thyroid carcinoma. Clin Nucl Med. 2008;33(9):638–640.
Google Scholar | Crossref | Medline22. Shapiro, B, Rufini, V, Jarwan, A, et al. False-Positive Radioiodine Scans in Thyroid Cancer. Springer, 2016. doi:10.1007/978-1-4939-3314-3_13
Google Scholar23. Kulkarni, K, Van Nostrand, D, Atkins, F, Mete, M, Wexler, J, Wartofsky, L. Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered? Nucl Med Commun. 2014;35(2):210–216.
Google Scholar | Crossref | Medline24. Liu, B, Huang, R, Kuang, A, et al. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer. Med Phys. 2011;38(10):5412–5419.
Google Scholar | Crossref | Medline25. Komen, MMC, Breed, WPM, Smorenburg, CH, et al. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer. 2016;24(6):2735–2741.
Google Scholar | Crossref | Medline26. van Kalmthout, LWM, Lam, MGEH, de Keizer, B, et al. Impact of external cooling with icepacks on 68Ga-PSMA uptake in salivary glands. EJNMMI Res. 2018;8(1):56. doi:10.1186/s13550-018-0408-2
Google Scholar | Crossref | Medline27. Ruigrok, EAM, Van Weerden, WM, Nonnekens, J, de Jong, M. The future of PSMA-targeted radionuclide therapy : an overview of recent preclinical research. Pharmaceutics. 2019;11(11):560.
Google Scholar | Crossref